drugset / Trial / NCT00180791

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

NCT00180791

Phase 2 Unknown 71 enrolled Gustave Roussy, Cancer Campus, Grand Paris
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of the combination of surgery, conventional chemotherapy, sequential high-dose chemotherapy with peripheral blood stem cell transplantation and reduced dose radiation therapy in high-risk PNET brain tumors.

Timeline

Start
2002-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule
Subject Cisplatin Other / unclassified
Subject Etoposide Small molecule
Subject Melphalan Small molecule
Subject Thiotepa Other / unclassified